Paul J Moberg

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members
    Paul J Moberg
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3400 Spruce St, Philadelphia, PA 19104, USA
    Am J Psychiatry 162:788-90. 2005
  2. ncbi Phenylthiocarbamide (PTC) perception in Parkinson disease
    Paul J Moberg
    Parkinson s Disease Research, Education, and Clinical Center, Philadelphia Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Cogn Behav Neurol 20:145-8. 2007
  3. ncbi Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Clin Exp Neuropsychol 28:1444-61. 2006
  4. ncbi Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia
    Paul J Moberg
    Brain Behavior Laboratory, Department of Psychiatry, 10th Floor, Gates Building, University of Pennsylvania School of Medicine, 3400 Spruce St, Philadelphia, PA 19104, USA
    Am J Psychiatry 161:2314-6. 2004
  5. ncbi Evaluation of competency: ethical considerations for neuropsychologists
    Paul J Moberg
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Appl Neuropsychol 13:101-14. 2006
  6. ncbi Apolipoprotein E genotype and odor identification in schizophrenia
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    J Neuropsychiatry Clin Neurosci 18:231-3. 2006
  7. ncbi Impairment of odor hedonics in men with schizophrenia
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, the Smell and Taste Center, PA 1914, USA
    Am J Psychiatry 160:1784-9. 2003
  8. pmc Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Schizophr Res 90:221-8. 2007
  9. ncbi Scent of a disorder: olfactory functioning in schizophrenia
    Paul J Moberg
    Department of Psychiatry, Brain Behavior Laboratory, University of Pennsylvania School of Medicine, 10th Floor Gates Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Curr Psychiatry Rep 5:311-9. 2003
  10. pmc The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth
    Vidyulata Kamath
    Neuropsychiatry Section, Department of Psychiatry, Philadelphia, PA, USA Smell and Taste Center, Department of Otorhinolaryngology Head and Neck Surgery, Perelman School of Medicine, Philadelphia, PA, USA Division of Medical Psychology, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA Electronic address
    J Psychiatr Res 47:1636-41. 2013

Collaborators

Detail Information

Publications64

  1. ncbi Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members
    Paul J Moberg
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3400 Spruce St, Philadelphia, PA 19104, USA
    Am J Psychiatry 162:788-90. 2005
    ..The authors examined PTC sensitivity in schizophrenia patients and their non-ill relatives to determine whether this represented a vulnerability marker...
  2. ncbi Phenylthiocarbamide (PTC) perception in Parkinson disease
    Paul J Moberg
    Parkinson s Disease Research, Education, and Clinical Center, Philadelphia Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Cogn Behav Neurol 20:145-8. 2007
    ..To examine phenylthiocarbamide (PTC) sensitivity in Parkinson disease (PD) patients and healthy volunteers to determine whether taster status represented a simple vulnerability marker for PD...
  3. ncbi Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Clin Exp Neuropsychol 28:1444-61. 2006
    ....
  4. ncbi Smaller nasal volumes as stigmata of aberrant neurodevelopment in schizophrenia
    Paul J Moberg
    Brain Behavior Laboratory, Department of Psychiatry, 10th Floor, Gates Building, University of Pennsylvania School of Medicine, 3400 Spruce St, Philadelphia, PA 19104, USA
    Am J Psychiatry 161:2314-6. 2004
    ....
  5. ncbi Evaluation of competency: ethical considerations for neuropsychologists
    Paul J Moberg
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Appl Neuropsychol 13:101-14. 2006
    ..The purpose of this article is to examine these issues in the context of neuropsychological practice...
  6. ncbi Apolipoprotein E genotype and odor identification in schizophrenia
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    J Neuropsychiatry Clin Neurosci 18:231-3. 2006
    ..No significant associations between ApoE status and olfaction were observed in either diagnostic group. The authors concluded that olfactory deficits in schizophrenia do not appear to be mediated by the ApoE allele...
  7. ncbi Impairment of odor hedonics in men with schizophrenia
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, the Smell and Taste Center, PA 1914, USA
    Am J Psychiatry 160:1784-9. 2003
    ..This study examined intensity and hedonic judgments in patients with schizophrenia to determine whether these functions were differentially impaired...
  8. pmc Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance
    Paul J Moberg
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Schizophr Res 90:221-8. 2007
    ..Phenotypic variation in PTC sensitivity is thought to be genetic in origin and suggests greater illness risk for those subjects with recessive taster alleles...
  9. ncbi Scent of a disorder: olfactory functioning in schizophrenia
    Paul J Moberg
    Department of Psychiatry, Brain Behavior Laboratory, University of Pennsylvania School of Medicine, 10th Floor Gates Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Curr Psychiatry Rep 5:311-9. 2003
    ..Because the olfactory system continuously regenerates throughout life, it allows for a unique view of an ongoing neurodevelopmental process...
  10. pmc The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth
    Vidyulata Kamath
    Neuropsychiatry Section, Department of Psychiatry, Philadelphia, PA, USA Smell and Taste Center, Department of Otorhinolaryngology Head and Neck Surgery, Perelman School of Medicine, Philadelphia, PA, USA Division of Medical Psychology, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA Electronic address
    J Psychiatr Res 47:1636-41. 2013
    ..Further research examining the utility of odor valence measures as markers for psychosis risk is warranted. ..
  11. pmc Scents and nonsense: olfactory dysfunction in schizophrenia
    Bruce I Turetsky
    Department of Psychiatry, 10th Floor, Gates Building, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Schizophr Bull 35:1117-31. 2009
    ..This could help to clarify underlying brain mechanisms and facilitate identification of clinically relevant biomarkers...
  12. pmc Olfactory physiological impairment in first-degree relatives of schizophrenia patients
    Bruce I Turetsky
    Neuropsychiatry Division, Department of Psychiatry, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, USA
    Schizophr Res 102:220-9. 2008
    ..It is unclear, however, whether these behavioral abnormalities reflect basic olfactory sensory processing deficits or nonspecific disruptions of attention and cognition...
  13. pmc An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis
    Vidyulata Kamath
    Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
    Schizophr Res 138:280-4. 2012
    ..Odor-detection thresholds to two odorants that differ in the degree to which they activate intracellular cAMP were assessed in clinical risk and low-risk participants...
  14. pmc Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease
    James F Morley
    Parkinson s Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
    Mov Disord 26:2051-7. 2011
    ..Future prospective studies are warranted to assess whether hyposmia, a very early feature of Parkinson's disease, might be used to predict the appearance of other common nonmotor symptoms...
  15. ncbi Unirhinal olfactory function in schizophrenia patients and first-degree relatives
    David R Roalf
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Neuropsychiatry Clin Neurosci 18:389-96. 2006
    ....
  16. ncbi Low olfactory bulb volume in first-degree relatives of patients with schizophrenia
    Bruce I Turetsky
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania, USA
    Am J Psychiatry 160:703-8. 2003
    ..This study examined olfactory bulbs in patients' relatives to determine whether low bulb volume represents an endophenotypic marker of genetic vulnerability...
  17. ncbi Evidence for impaired encoding and retrieval memory profiles in Parkinson disease
    Daniel Weintraub
    Parkinson s Disease Research, Education and Clinical Center PADRECC, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
    Cogn Behav Neurol 17:195-200. 2004
    ..Specifically, we sought to ascertain whether the memory performance of PD patients can be categorized as fitting an unimpaired, an impaired retrieval, or an impaired encoding memory profile...
  18. pmc Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score
    Sarra Nazem
    Department of Psychiatry, University of Pennsyvania, Philadelphia, USA
    J Am Geriatr Soc 57:304-8. 2009
    ..To examine Montreal Cognitive Assessment (MoCA) performance in patients with Parkinson's disease (PD) with "normal" global cognition according to Mini-Mental State Examination (MMSE) score...
  19. pmc Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients
    Vidyulata Kamath
    Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Schizophr Bull 39:59-67. 2013
    ..We also examine odor valence processing unirhinally, rather than birhinally, to probe possible lateralized differences in patients' hedonic processing deficits...
  20. pmc Computerized neurocognitive test performance in schizophrenia: a lifespan analysis
    Farzin Irani
    Department of Psychiatry, Neuropsychiatry Section, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA
    Am J Geriatr Psychiatry 20:41-52. 2012
    ..Favorable construct validity in younger schizophrenia patients has been reported, but not in older patients. New variables afforded by computerized assessments were used to clarify age-associated cognitive impairment across the lifespan...
  21. ncbi Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Nucl Med 46:227-32. 2005
    ..We studied the correlation of striatal dopamine transporter (DAT) imaging with anxiety and depression symptoms in Parkinson's disease (PD)...
  22. ncbi Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease
    Daniel Weintraub
    Parkinson s Disease Research, Education and Clinical Center, Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
    J Am Geriatr Soc 52:784-8. 2004
    ..To examine the effect of depression and other nonmotor symptoms on functional ability in Parkinson's disease (PD)...
  23. ncbi Dimensions of executive function in Parkinson's disease
    Daniel Weintraub
    Parkinson s Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA 19104, USA
    Dement Geriatr Cogn Disord 20:140-4. 2005
    ..Executive impairment is common in Parkinson's disease (PD). However, it is unknown which dimensions of executive function are assessed by commonly used neuropsychological instruments and if clinical correlates of specific dimensions exist...
  24. ncbi Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia
    Bruce I Turetsky
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia 19104, USA
    Arch Gen Psychiatry 60:1193-200. 2003
    ..Patients with schizophrenia exhibit olfactory deficits, but it is unclear whether these represent a specific abnormality. The link between olfactory impairments and regional brain abnormalities has yet to be established...
  25. pmc Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia
    Bruce I Turetsky
    Schizophrenia Research Center, Department of Psychiatry, 10th Floor, Gates Building, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, Pennsylvania, 19104, USA
    Schizophr Res 93:237-44. 2007
    ....
  26. pmc Facial emotion perception in schizophrenia: a meta-analytic review
    Christian G Kohler
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Schizophr Bull 36:1009-19. 2010
    ..0 (Borenstein M, Hedges L, Higgins J and Rothstein H. Comprehensive Meta-analysis. 2. Englewood, NJ: Biostat; 2005)...
  27. pmc Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores
    Eugenia Mamikonyan
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Parkinsonism Relat Disord 15:226-31. 2009
    ..We report on the frequency and characteristics of cognitive deficits in PD patients with intact global cognition based on Mini-Mental State Examination (MMSE) performance...
  28. pmc Verbal learning and memory in older adults with minor and major depression
    Raquelle I Mesholam-Gately
    Harvard Medical School, Department of Psychiatry, Massachusetts Mental Health Center, Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Arch Clin Neuropsychol 27:196-207. 2012
    ..The findings suggest that depression in the elderly is a heterogeneous entity and that the CVLT may be a useful tool for characterizing learning and memory in late-onset depressive disorders...
  29. pmc Medication management and neuropsychological performance in Parkinson's disease
    Kevin J Manning
    Department of Psychology, Drexel University, Philadelphia, PA 19104, USA
    Clin Neuropsychol 26:45-58. 2012
    ..A range of neuropsychological abilities is associated with the ability to understand and implement a medication schedule and pillbox in individuals with PD...
  30. ncbi Physiologic impairment of olfactory stimulus processing in schizophrenia
    Bruce I Turetsky
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Biol Psychiatry 53:403-11. 2003
    ..Only limited efforts have been made to investigate the neurophysiologic substrate of these olfactory abnormalities. This article reports the first examination of olfactory electrophysiologic responses in patients with schizophrenia...
  31. pmc Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging
    David R Roalf
    Department of Psychiatry, Neuropsychiatry, University of Pennsylvania, Philadelphia, PA, USA
    Alzheimers Dement 9:529-37. 2013
    ....
  32. pmc Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis
    Paul J Moberg
    To whom correspondence should be addressed 10 Gates, HUP, 3400 Spruce Street, Philadelphia, PA 19104, US tel 215 615 3608, fax 215 662 7903, E mail
    Schizophr Bull 40:50-9. 2014
    ..Thus, the current meta-analysis was undertaken to incorporate additional studies, risk cohorts, olfactory test domains, and moderator variable analyses...
  33. pmc Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults
    Sarah C Seligman
    Department of Psychology, Temple University, Philadelphia, PA, USA
    Aging Ment Health 17:564-70. 2013
    ....
  34. pmc Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies
    Farzin Irani
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Schizophr Bull 37:1318-26. 2011
    ..Previous reviews have focused on the nature and course of cognitive impairments in younger cohorts, but a quantitative meta-analysis in older patients is pending...
  35. pmc Neurodegeneration across stages of cognitive decline in Parkinson disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, 3615 Chestnut St, Ste 330, Philadelphia, PA 19104, USA
    Arch Neurol 68:1562-8. 2011
    ..To assess regions and patterns of brain atrophy in patients with Parkinson disease (PD) with normal cognition (PD-NC), mild cognitive impairment (PD-MCI), and dementia-level cognitive deficits (PDD)...
  36. pmc An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia
    Bruce I Turetsky
    Department of Psychiatry, University of Pennsylvania, 10th Floor, Gates Building, 3400 Spruce St, Philadelphia, PA 19104, USA
    Am J Psychiatry 166:226-33. 2009
    ..This study was designed to test this hypothesis by determining odor detection threshold sensitivities to two odorants that differ in their relative activations of this intracellular cAMP signaling cascade...
  37. ncbi Relationship between clock-drawing and neuropsychological and functional status in elderly institutionalized patients with schizophrenia
    Natasha Lowery
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Am J Geriatr Psychiatry 11:621-8. 2003
    ..The authors sought to examine the usefulness of the clock-drawing test (CDT) as a measure of general cognitive and adaptive functioning in elderly patients with schizophrenia...
  38. pmc Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
    Parkinsonism Relat Disord 12:427-31. 2006
    ..02), depression with mild-cognitive impairment (P=.03), and their co-occurrence with higher daily levodopa dosages (P<.01). These results suggest that psychosis and depression in PD are distinct neurobehavioral disorders...
  39. ncbi Association between facial emotion recognition and odor identification in schizophrenia
    Christian G Kohler
    Schizophrenia Research Center, University of Pennsylvania, Department of Psychiatry, 10th Floor, Gates Building, 3400 Spruce Street, Philadelphia, PA 19104, USA
    J Neuropsychiatry Clin Neurosci 19:128-31. 2007
    ..Olfactory and emotion recognition abilities appear significantly linked in schizophrenia...
  40. ncbi Normative data for the symbol cancellation test in young healthy adults
    Natasha Lowery
    Brain Behavior Laboratory, Department of Psychiatry, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Appl Neuropsychol 11:218-21. 2004
    ..In addition, a relation likely exists between SCT performance and age and education, but a larger sample seems warranted to reliably model the pattern...
  41. pmc Depth of the olfactory sulcus: a marker of early embryonic disruption in schizophrenia?
    Bruce I Turetsky
    Neuropsychiatry Division, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, USA
    Schizophr Res 115:8-11. 2009
    ..Olfactory and orbital sulcal depths were correlated in controls, but not in patients. Olfactory sulcal depth may therefore be a biomarker denoting an early embryonic disruption in individuals at risk for schizophrenia...
  42. ncbi Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis
    Christian G Kohler
    University of Pennsylvania, Department of Psychiatry, Philadelphia, PA, United States Electronic address
    Psychiatry Res 216:206-12. 2014
    ..Preliminary results with clinical high-risk participants, when considered along findings in genetic risk relatives, suggest social cognition abilities to reflect pathophysiological processes involved in risk of schizophrenia. ..
  43. pmc Antidepressant studies in Parkinson's disease: a review and meta-analysis
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Mov Disord 20:1161-9. 2005
    ..In addition, PD patients may benefit less from antidepressant treatment, particularly selective serotonin reuptake inhibitors, than do elderly patients without PD...
  44. ncbi Decision-making capacity and competency in the elderly: a clinical and neuropsychological perspective
    Paul J Moberg
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    NeuroRehabilitation 23:403-13. 2008
    ..The importance of assessing decision-making capacity in the context of specific functions and of respecting the values and interests of older adults are emphasized...
  45. ncbi Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel
    William C Culbertson
    Drexel University, Neuropsychology Program, Philadelphia, PA 19104, USA
    Assessment 11:27-39. 2004
    ..Support was found for the convergent and divergent validity of the TOLDX. The clinical and theoretical implications of the findings are discussed...
  46. pmc Olfactory receptor neuron dysfunction in schizophrenia
    Bruce I Turetsky
    Neuropsychiatry Division, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
    Neuropsychopharmacology 34:767-74. 2009
    ..It unambiguously demonstrates that neurophysiological disturbances in schizophrenia are not limited to cortical and subcortical structures, but rather include even the most peripheral sensory neurons...
  47. ncbi Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures
    Bruce I Turetsky
    Department of Psychiatry, University of Pennsylvania Medical Center, Philadelphia 19104, USA
    Neuropsychology 16:481-90. 2002
    ..Unimpaired patients had fewer negative symptoms and dorsal medial prefrontal hypermetabolism. The authors conclude that categorizing patients on the basis of memory deficits may yield neurobiologically meaningful disease subtypes...
  48. pmc The influence of semantic processing on odor identification ability in schizophrenia
    Vidyulata Kamath
    Neuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    Arch Clin Neuropsychol 28:254-61. 2013
    ..No relationship was observed between olfactory and semantic task performance in patients. These data suggest that odor identification deficits may not be primarily due to semantic processing deficits in schizophrenia...
  49. ncbi Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine
    Farzin Irani
    Division of Neuropsychiatry, Department of Psychiatry, Stanley Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA
    Neuropsychopharmacology 29:960-8. 2004
    ..Thus, the study provides impetus for future work in this area...
  50. doi Association of schizophrenia with the phenylthiocarbamide taste receptor haplotype on chromosome 7q
    Paul J Moberg
    Neuropsychiatry Section, Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
    Psychiatr Genet 22:286-9. 2012
    ..The PTC nontaster haplotype is a genetic marker that may be used to identify subsets of schizophrenia patients who potentially harbor vulnerability genes in this region of chromosome 7q...
  51. pmc Identification of pleasant, neutral, and unpleasant odors in schizophrenia
    Vidyulata Kamath
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Psychiatry Res 187:30-5. 2011
    ....
  52. ncbi Recognition and treatment of depression in Parkinson's disease
    Daniel Weintraub
    Parkinson s Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, USA
    J Geriatr Psychiatry Neurol 16:178-83. 2003
    ..Most depressed patients are untreated, and half of antidepressant users remain depressed, suggesting that even when delivered, treatment is often inadequate or ineffective...
  53. pmc Association of dopamine agonist use with impulse control disorders in Parkinson disease
    Daniel Weintraub
    Department of Psychiatry, University of Pennsylvania, and Parkinson s Disease Research, Education, and Clinical Center, USA
    Arch Neurol 63:969-73. 2006
    ..To determine the frequency and correlates of impulse control disorders (ICDs) in Parkinson disease (PD)...
  54. pmc Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia
    Vidyulata Kamath
    Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    Behav Neurosci 126:209-15. 2012
    ..Future studies that examine the olfactory processing deficit in schizophrenia with respect to other olfactory measures and COMT haplotypes is warranted...
  55. doi Facial emotion perception in depression and bipolar disorder: a quantitative review
    Christian G Kohler
    Schizophrenia Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Psychiatry Res 188:303-9. 2011
    ..Emotion perception impairment in bipolar disorder and major depressive disorder represents a moderate and stable deficit that appears to be moderated by a limited number of demographic and clinical factors...
  56. ncbi Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease
    Thomas McBride
    Brain Behaviour Laboratory, Department of Psychiatry, 10th Floor, Gates Building, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia 19104, USA
    Schizophr Res 55:217-27. 2002
    ..Though the specific histopathology of the two disorders differs, abnormalities in the common sites may underlie the common neuropsychological profile...
  57. pmc Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease
    Steven E Arnold
    Alzheimer s Disease Core Center, University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Neurol 67:462-9. 2010
    ..However, their frequency, abundance, and disease specificity, and the relationships of OE pathology to brain pathology have not been established...
  58. pmc Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness
    Felix Geser
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 4283, USA
    Arch Neurol 67:1238-50. 2010
    ....
  59. pmc The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults
    Ariel G Gildengers
    Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Bipolar Disord 12:851-8. 2010
    ..We also examine whether there are negative, synergistic effects between lifetime duration of BD and vascular disease burden on cognition...
  60. ncbi The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration
    Matthew M Kurtz
    Department of Psychiatry, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA
    Arch Clin Neuropsychol 19:191-201. 2004
    ..Divergent validity was established through low, nonsignificant correlations between the PCET and measures of facial emotion recognition, word and face memory, visuospatial function, and verbal reasoning...
  61. ncbi Neuropsychological deficits among patients with late-onset minor and major depression
    Virginia Elderkin-Thompson
    Neuropsychiatric Research Institute and Hospital, University of California, 760 Westwood Plaza C8 688, Los Angeles, CA 90024 1759, USA
    Arch Clin Neuropsychol 18:529-49. 2003
    ..This decline in cognitive performance parallels a similar trend observed in neuroanatomical studies in which the volume of the frontal and temporal lobes decrease with increasing severity of depression...
  62. ncbi Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study
    Matthew M Kurtz
    Schizophrenia Rehabilitation Program, Neuropsychiatry Research Center, Institute of Living, 200 Retreat Avenue, Hartford, CT 06106, USA
    Schizophr Bull 31:167-74. 2005
    ..The significance of these findings for the development and assessment of novel treatment interventions for schizophrenia is discussed...
  63. ncbi Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life
    Galit Kleiner-Fisman
    Philadelphia Parkinson s Disease Research Education and Clinical Center, Philadelphia Veterans Administration Hospital, USA
    J Neurosurg 107:29-36. 2007
    ..Outcomes have varied depending on the features of the dystonia. There has been limited literature regarding outcomes for refractory dystonia following DBS of the subthalamic nucleus (STN)...
  64. ncbi The TCN/AACN 2005 "salary survey": professional practices, beliefs, and incomes of U.S. neuropsychologists
    Jerry J Sweet
    Evanston Northwestern Healthcare, Evanston, IL 60201, USA
    Clin Neuropsychol 20:325-64. 2006
    ..While higher than reported by other types of psychologists, neuropsychology incomes have lagged behind inflation when compared to 1992 data. Numerous breakdowns related to income and professional activities are provided...